Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Amphion Innovations optimistic on improving valuation

Amphion Innovations optimistic on improving valuation

Amphion Innovations (LON:AMP) reckons if market conditions continue to improve, it could see a recovery in its overall value.

It is invested in seven partner medical and tech focused companies, aiming to grow their value but 2013 was another challenging year, it said.

"The bad economic climate of the last few years has demanded continued attention to the evolution of these business models so they can be adapted to a different and generally harsher market environment," it said.

"Although the pace of advance remains frustratingly slow, most of our partner companies continue to hold promise and are making progress."

A key development in 2013 was the float of imaging specialist Kromek, in which it holds a 10.6% stake, completed in early October. It raised £15 million before expenses, as targeted.

However, as reported previously, a set back came in March when Kromek said revenues for its year to end April would be "significantly below the market's expectations". Amphion believes howver the firm has an exciting future ahead.

This month the firm was granted a loan facility by an institutional lender to further its partner companies and its IP programmes.

It has already drawn down US$2 million with a further draw down facility of up to a maximum of US $10 million.

Richard Morgan, Amphion's chief executive said: "We and our advisors remain steadfast in our belief in the strength and validity of the DataTern patents.  With the Appeals Court decision in hand and activity under way with that court to strengthen our hand, we expect to see some tangible progress in these programmes during the next six to twelve months.

 "Although we remain cautious, the recovery in the stock market and the IPO market in particular has led to an improvement in the overall climate for our business.  If conditions continue to improve, we believe we should start to see a recovery in the net asset value.  Progress by Kromek will be a key driver of such a recovery but developments within DataTern and the other partner companies will be equally important."

The loss before tax in 2013 was US$6.385mln compared to a loss of US$6.94mln in 2012. Revenue was US$1.01mln (2012: US$1.39mln).

View full AMP profile View Profile

Amphion Innovations Plc Timeline

Related Articles

VW-plant.jpg
October 10 2017
Mike McAuliffe reckons the company's technology is 'tremendous', it is just a case of making the most of it commercially
Buying online
November 14 2017
The company toned down full-year revenue guidance after a review of procedures but is still growing like topsy
x-ray image
September 04 2017
The radiation detection specialist is expecting revenues to grow by at least 40% this year after spending a couple of years laying the foundations

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use